Skip to main content
CellaVision logo

CellaVision — Investor Relations & Filings

Ticker · CEVI ISIN · SE0000683484 LEI · 529900IUBZBZ0HXFJ114 ST Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2015-02-12 Interim / Quarterly Rep…
Country SE Sweden
Listing ST CEVI

About CellaVision

https://www.cellavision.com/

CellaVision is a medical technology company that provides digital solutions for cell morphology in hematology. The company specializes in automating and standardizing the analysis of blood and other body fluids for both human and veterinary applications. Its core offerings include a complete system of analyzers, instruments, software, and reagents designed for hematology laboratories of all sizes. By utilizing patented technology that integrates automated microscopy, advanced image analysis, and artificial intelligence, CellaVision's systems digitize the traditional manual review of blood smears. This automation enhances laboratory workflow efficiency, improves diagnostic accuracy, and facilitates remote collaboration among healthcare professionals, advancing diagnostic certainty.

Recent filings

Filing Released Lang Actions
CellaVision Year-end bulletin 2014
Interim / Quarterly Report Classification · 1% confidence The document is a 'Year-end bulletin 2014' for CellaVision, covering the period October 1–December 31, 2014, and the full year 2014. It contains detailed financial statements (Net sales, Operating profit, Earnings per share, Cash flow), management commentary, and key ratios. It is a comprehensive financial report for a period shorter than a full fiscal year (Q4 and full-year summary), which fits the definition of an Interim/Quarterly Report. Q4 2014
2015-02-12 English
CellaVision AB får sin första större order på veterinärmarknaden
Regulatory Filings Classification · 1% confidence The document is a short announcement detailing a specific business event: CellaVision receiving its first major order in the veterinary market worth approximately 10 million SEK, with delivery expected before year-end. It includes quotes from the CEO, product context, and contact information. It is not a comprehensive annual report (10-K), an interim report (IR), a formal earnings release (ER) with full financials, or a transcript (CT). Given its nature as a specific, material business update that doesn't fit the other specific categories (like M&A, Capital Change, Dividend), it most closely aligns with a general regulatory announcement or a specific news release. Since it is a material, non-financial-statement-focused announcement, and it is short (3536 chars), it fits best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for significant, non-standard announcements, or potentially a very specific type of 'Capital/Financing Update' (CAP) if the order was deemed a major financing event, but it is clearly a sales/order announcement. RNS is the most appropriate general category for this type of material news release that isn't a core financial filing.
2014-12-11 Swedish
CellaVision AB receives its first major order for the veterinary market
Regulatory Filings Classification · 1% confidence The document announces a significant event: CellaVision receiving its first major order for veterinary equipment worth approximately 10 million SEK. It includes quotes from the CEO, details about the market context (veterinary diagnostics), and concludes with contact information and an 'About CellaVision' section, ending with a specific release time and date: "This information was released for public disclosure on December 11, 2014 at 08.20 pm CET." This structure strongly suggests an immediate public disclosure of material, non-public information, which is characteristic of an Earnings Release (ER) or a general Regulatory Filing (RNS). Since it is not a full financial report (10-K, IR) or a transcript (CT), and it focuses on a major business development/order rather than just dividends (DIV) or management changes (MANG), it fits best as an Earnings Release (ER) which often includes key operational highlights outside of the standard quarterly reporting cycle, or as a general Regulatory Filing (RNS). Given the nature of announcing a major contract, ER is plausible, but RNS is the safest general regulatory announcement category for material news that isn't a formal earnings report. However, since it details a significant business event and financial impact (10M SEK order), it functions similarly to an Earnings Release highlighting operational success. Given the options, and the lack of a formal 'Earnings Release' header, RNS is the most appropriate fallback for a material, time-stamped announcement of a major contract win.
2014-12-11 English
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for the period January–September 2014. It contains comprehensive financial statements, including income statements, balance sheet data, cash flow analysis, management commentary, and notes on accounting principles. It is not an announcement of a report (RPA) as it contains the full substantive financial data for the period. Therefore, it is classified as an Interim/Quarterly Report. 9M 2014
2014-11-05 Swedish
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Report January-September 2014' and contains comprehensive financial statements, key ratios, CEO commentary, and operational analysis for the specified period. It adheres to the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. 9M 2014
2014-11-05 English
CellaVision AB: Delårsrapport januari-september 2014
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for the period January–September 2014. It contains comprehensive financial statements, including income statements, balance sheet data, cash flow analysis, management commentary, and notes on accounting principles. It is not an announcement of a report (RPA) as it contains the full substantive financial data for the period. Therefore, it is classified as an Interim/Quarterly Report. 9M 2014
2014-11-05 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.